# NIO Inc.: Form 20-F for the period ended Dec 31, 2025

- Company: [NIO Inc.](/companies/nio.md) (CIK 1736541)
- Form: 20-F
- Filed: 2026-04-10
- Accepted by EDGAR: Apr 10, 2026, 07:54 ET
- Period: 2025-12-31
- Accession: 0001104659-26-041765
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1736541/000110465926041765/nio-20251231x20f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1736541/000110465926041765/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2025-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2025-01-01 to 2025-12-31 | $12.51bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months, 2025-01-01 to 2025-12-31 | $10.81bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months, 2025-01-01 to 2025-12-31 | $1.70bn | us-gaap:GrossProfit |
| Research and development | 12 months, 2025-01-01 to 2025-12-31 | $1.52bn | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months, 2025-01-01 to 2025-12-31 | $2.30bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months, 2025-01-01 to 2025-12-31 | −$2.01bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2025-01-01 to 2025-12-31 | $126.6m | us-gaap:InterestExpense |
| Income tax | 12 months, 2025-01-01 to 2025-12-31 | $17.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2025-01-01 to 2025-12-31 | −$2.14bn | us-gaap:ProfitLoss |
| Diluted EPS | 12 months, 2025-01-01 to 2025-12-31 | −$0.98 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2025-01-01 to 2025-12-31 | −$0.98 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2025-01-01 to 2025-12-31 | 2,272,635,997 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2025-01-01 to 2025-12-31 | $427.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2025-01-01 to 2025-12-31 | $867.3m | us-gaap:PaymentsToAcquireProductiveAssets |
| Cash and equivalents | at 2025-12-31 | $1.61bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2025-12-31 | $10.96bn | us-gaap:AssetsCurrent |
| Total assets | at 2025-12-31 | $17.79bn | us-gaap:Assets |
| Current liabilities | at 2025-12-31 | $11.24bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2025-12-31 | $15.97bn | us-gaap:Liabilities |
| Long-term debt | at 2025-12-31 | $1.23bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2025-12-31 | $93.8m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | at 2025-12-31 | $670.9m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2025-12-31 | $594.8m | us-gaap:StockholdersEquity |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1736541/000110465926041765/nio-20251231x20f.htm

Filed Apr 10, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-041765. Last ingested by Listed: Nov 6, 2026, 16:33 ET. No prices; not investment advice.